BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data In Phase III Program

		HER2 Support Group Forums > Breast Cancer Newsfeed
BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data In Phase III Program

02-24-2010, 06:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,051	BioSante Pharmaceuticals Reports Positive LibiGel(R) Safety Data In Phase III Program BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX), announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study... More...

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 02:30 AM.